The mechanism by which CurNisNp prevents myocardial infarction includes its ability to increase the activity of the cardiac antioxidant defense which was accompanied with significantly lower levels of ROS, MDA, and CTnI expression in the heart when compared with isoproterenol alone treated animals. This evidence concerns the gene TNNI3 and myocardial infarction.